• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, May 10

JB Chemicals & Pharmaceuticals Ltd has posted a 35 per cent growth in its profit after tax (PAT) for the fourth quarter ended March 31, 2006. The company clocked a PAT of Rs 15.45 crore compared to Rs 11.44 crore in the corresponding period last year. Total income (net of excise) has increased to Rs 117.07 crore (Rs 85.55 crore). For the full-year, the company posted a profit after tax of Rs 70.92 crore (Rs 59.14 crore). Total income (net of excise) has increased to Rs 477.55 crore (Rs 371.11 crore). The Group posted a net profit attributable to parent of Rs 70.23 crore for the year ended March 31, 2006, as compared to Rs 58.34 crore for the year ended March 31, 2005. The board has recommended a final dividend at Rs 1.50 per equity share of Rs 2 each, for the financial year ended 2005-06. It has also approved the amalgamation of Lekar Healthcare Ltd, wholly-owned subsidiary, into the holding Company. JB Chemicals & Pharmaceuticals shares closed at Rs 116.55, up 2.64 per cent on the BSE.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Alps Industries Q4 net up 51 pc

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line